IFC mulls up to $200m loan for China's COVID-19 vaccine maker Fosun Pharma

IFC mulls up to $200m loan for China's COVID-19 vaccine maker Fosun Pharma

Photo by Mufid Majnun on Unsplash

27 May, 2021

BioNTech COVID-19 IFC Pfizer Shanghai Fosun Pharmaceutical vaccine

Printed by Unregistered user on Wed, 20 Aug 2025 19:50:33 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

COVID vaccine maker Serum Institute of India turned down $1 b offer from PE firms last year

China’s Sinovac secures $515m to boost COVID-19 vaccine production

Read more from Greater China

Policy & Regulations

China considering yuan-backed stablecoins to boost currency’s global usage: report

PE secondary deals in China to surge on rising supply, cheaper valuations